<- Go home

Added to YB: 2026-01-08

Pitch date: 2025-12-30

USAQ [neutral]

QHSLab, Inc.

+71.12%

current return

Author Info

Company Info

QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures.

Market Cap

$9.6M

Pitch Price

$0.52

Price Target

N/A

Dividend

N/A

EV/EBITDA

45.71

P/E

-20.95

EV/Sales

4.21

Sector

Health Care Technology

Category

turnaround

Show full summary:
Letter 2025 - Mexican Investor: Key players - QHSLab, Inc.

USAQ (holding update): Sells AllergiEnd allergy testing systems w/ complementary software for evaluation & treatment. Recently repurchased $1.4M legacy debt (significant for $5M market cap co). Without debt, biz would grow sales 25-30% & has been operationally profitable 6 of last 7 quarters.

Read full article (1 min)